Novavax stock $NVAX is the best for day traders today

News reports say that Novavax and Sanofi will join forces to develop a covid 19 vaccine valued at 1.4 billion dollars. The stock surged for a short period of time and then pulled back and remained about a 100% increase. The trade volume is decent: 140 shares traded and turnover% exceeding 400%. But traders' enthusiasm is still limited.

If traders can seize the momentum, they certainly can make some decent money. But most of time, the trading volume has not been good for day traders.